Regional Technology Development

Regional Technology Development (RTD) is an Israeli medical technology company that serves as the core research and development subsidiary for GlucoTrack. The company is dedicated to the design and commercialization of non-invasive glucose monitoring devices for patients with type 2 diabetes and pre-diabetes. Its primary innovation, the GlucoTrack system, employs a multi-sensor approach—combining ultrasonic, electromagnetic, and thermal technologies—to measure glucose levels via a clip attached to the earlobe. This technology eliminates the need for painful finger-stick blood sampling, aiming to increase patient compliance and improve glycemic control. RTD continues to advance the platform's accuracy and form factor to support global commercialization efforts.